NEWS & RELEASE

• November 1, 2023 Launch of Distribution of the OptiLight M22 IPL Model（PDF）
• September 7, 2023 Launch of Distribution of “Smart MIEr”（PDF）
• March 22, 2023 Senju initiated Phase III Clinical Trials in Japan for “SJP-0132” for the treatment of Dry Eye Disease. The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju（PDF）
• February 27, 2023 Announcement of collaboration agreement with Alchemedicine, Inc.（PDF）